The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients-Reference-Cited by-同舟云学术

The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients

Published:2012-05 Issue:5 Volume:22 Page:373-380
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Elens Laure,Bouamar Rachida,Hesselink Dennis A.,Haufroid Vincent,van Gelder Teun,van Schaik Ron H.N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference50 articles.

1. The use of cyclosporine in renal transplantation.;Hesselink;Transplant Proc,2004

2. In vitro metabolism of cyclosporine A by human kidney CYP3A5.;Dai;Biochem Pharmacol,2004

3. The drug transporter-metabolism alliance: uncovering and defining the interplay.;Benet;Mol Pharmacol,2009

4. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans.;Danielson;Curr Drug Metab,2002

5. Genetic contribution to variable human CYP3A-mediated metabolism.;Lamba;Adv Drug Deliv Rev,2002

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study;Frontiers in Pharmacology;2024-07-29

2. CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study;Frontiers in Pharmacology;2023-07-04

3. Model‐Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy;Clinical Pharmacology & Therapeutics;2023-06-25

4. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics;European Journal of Human Genetics;2023-03-31

5. Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity;Frontiers in Pharmacology;2022-06-16